HB1357
Type: B Origin: House Texas Comments: 0

Relating To Medicaid Reimbursement For Certain Medication-Assisted Treatments For Opioid Or Substance Use Disorder.

Summary
User Reviews

AI Summary

This federal bill focuses on Medicaid reimbursement for specific medication-assisted treatments for opioid or substance use disorder. The main purpose is to ensure that individuals have better access to these treatments through Medicaid coverage. The bill outlines provisions related to reimbursement rates and requirements for healthcare providers offering such treatments. Its significant impact is expected to be an increase in availability and affordability of medication-assisted treatments for those struggling with opioid or substance use disorders.

Bill Activity

  • 2023-01-17: Filed

  • 2023-03-03: Read first time

  • 2023-03-03: Referred to Human Services

  • 2023-04-04: Scheduled for public hearing on . . .

  • 2023-04-04: Considered in public hearing

  • 2023-04-04: Testimony taken/registration(s) recorded in committee

  • 2023-04-04: Left pending in committee

  • 2023-04-11: Considered in public hearing

  • 2023-04-11: Reported favorably w/o amendment(s)

  • 2023-04-14: Comte report filed with Committee Coordinator

  • 2023-04-14: Committee report distributed

  • 2023-04-17: Committee report sent to Calendars

  • 2023-04-26: Considered in Calendars

  • 2023-04-28: Placed on General State Calendar

  • 2023-05-01: Read 2nd time

  • 2023-05-01: Amendment fails of adoption 1-Davis

  • 2023-05-01: Record vote RV#767

  • 2023-05-01: Statement(s) of vote recorded in Journal

  • 2023-05-01: Passed to engrossment

  • 2023-05-02: Read 3rd time

  • 2023-05-02: Passed

  • 2023-05-02: Record vote RV#797

  • 2023-05-02: Statement(s) of vote recorded in Journal

  • 2023-05-02: Reported engrossed

  • 2023-05-03: Received from the House

  • 2023-05-05: Read first time

  • 2023-05-05: Referred to Health & Human Services

  • 2023-05-18: Posting rule suspended

  • 2023-05-19: Scheduled for public hearing on . . .

  • 2023-05-19: Considered in public hearing

  • 2023-05-19: Vote taken in committee

  • 2023-05-21: Reported favorably w/o amendments

  • 2023-05-21: Recommended for local & uncontested calendar

  • 2023-05-21: Committee report printed and distributed

  • 2023-05-22: Co-sponsor authorized

  • 2023-05-23: Placed on local & uncontested calendar

  • 2023-05-24: Laid before the Senate

  • 2023-05-24: Read 2nd time & passed to 3rd reading

  • 2023-05-24: Vote recorded in Journal

  • 2023-05-24: Three day rule suspended

  • 2023-05-24: Record vote

  • 2023-05-24: Read 3rd time

  • 2023-05-24: Passed

  • 2023-05-24: Record vote

  • 2023-05-25: Senate passage reported

  • 2023-05-26: Reported enrolled

  • 2023-05-27: Signed in the House

  • 2023-05-29: Signed in the Senate

  • 2023-05-30: Sent to the Governor

  • 2023-06-13: Signed by the Governor

  • 2023-06-13: Effective immediately

Overall Bill Rating

0.0
0.0
0.0
0.0
0.0
0.0
Roll Calls (4):
  • Chamber: Senate
  • Date of Vote: 2023-05-24
  • Vote Summary: Three day rule suspended
  • Votes in Favor: 31
  • Chamber: Senate
  • Date of Vote: 2023-05-24
  • Vote Summary: Read 3rd time
  • Votes in Favor: 31
Amendments (1):
  • Name: House Amendment (H 2) 1-Davis
  • BillId: HB1357
  • LegislativeSession: 2023 Regular Session
  • Description: House Amendment (H 2) 1-Davis
  • FloorActionDate: 2023-05-01
  • Pdf:  HB01357H21.HTM
Bill Discussion Board

Share your views on the Bill

User Icon

Min. 50 characters required  |  (0/1000 Character)

Contributions (0)
Add Contribution+2 pts.

Contribute Your Insights: Add a Unique Perspective to Political Bills. Your Contribution will be Featured Below the Primary Bill, Ordered by Date Added.